BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists

Reuters

19 Feb

BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists

Feb 19 (Reuters) - Immunitybio Inc IBRX.O:

FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE® BCG SHORTAGE
IMMUNITYBIO INC: SUPPLIES OF RBCG ARE NOW AVAILABLE, WITH SHIPMENTS SET TO BEGIN IMMEDIATELY VIA AN FDA EXPANDED ACCESS PROGRAM
IMMUNITYBIO INC - THOUSANDS OF VIALS OF RBCG AVAILABLE TO END TICE BCG SHORTAGE

Source text: nBwc1xmZza

Further company coverage: IBRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2512850134"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2512850134\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2512850134?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-19 23:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512850134","market":"us","top_or_hot":-1,"title":"BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists</title></head><body><p><span>Feb 19 (Reuters)</span><span> - </span>Immunitybio Inc <span>IBRX.O</span>:</p><ul><li><p>FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE® BCG SHORTAGE</p></li><li><p>IMMUNITYBIO INC: SUPPLIES OF RBCG ARE NOW AVAILABLE, WITH SHIPMENTS SET TO BEGIN IMMEDIATELY VIA AN FDA EXPANDED ACCESS PROGRAM</p></li><li><p>IMMUNITYBIO INC - THOUSANDS OF VIALS OF RBCG AVAILABLE TO END TICE BCG SHORTAGE</p></li></ul><p>Source text: <span>nBwc1xmZza</span></p><p>Further company coverage: <span>IBRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-19 23:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To Urologists</title></head><body><p><span>Feb 19 (Reuters)</span><span> - </span>Immunitybio Inc <span>IBRX.O</span>:</p><ul><li><p>FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE® BCG SHORTAGE</p></li><li><p>IMMUNITYBIO INC: SUPPLIES OF RBCG ARE NOW AVAILABLE, WITH SHIPMENTS SET TO BEGIN IMMEDIATELY VIA AN FDA EXPANDED ACCESS PROGRAM</p></li><li><p>IMMUNITYBIO INC - THOUSANDS OF VIALS OF RBCG AVAILABLE TO END TICE BCG SHORTAGE</p></li></ul><p>Source text: <span>nBwc1xmZza</span></p><p>Further company coverage: <span>IBRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBRX","symbol_name":"ImmunityBio, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA2N4HW7:1","article_id":"2512850134","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512850134","pubTimestamp":1739978177,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To UrologistsFeb 19 (Reuters) - Immunitybio Inc IBRX.O:FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE BCG S","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IBRX":"ImmunityBio, Inc.","BK4139":"生物科技"},"translate_title":"简介-FDA授权ImmunityBio向泌尿科医生提供重组卡介苗(Rbcg)，以解决泰斯®卡介苗短缺问题","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBRX":0.9},"content_text":"BRIEF-FDA Authorizes Immunitybio To Provide Rbcg To UrologistsFeb 19 (Reuters) - Immunitybio Inc IBRX.O:FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE® BCG SHORTAGEIMMUNITYBIO INC: SUPPLIES OF RBCG ARE NOW AVAILABLE, WITH SHIPMENTS SET TO BEGIN IMMEDIATELY VIA AN FDA EXPANDED ACCESS PROGRAMIMMUNITYBIO INC - THOUSANDS OF VIALS OF RBCG AVAILABLE TO END TICE BCG SHORTAGESource text: nBwc1xmZzaFurther company coverage: IBRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}